Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NAVITUS HEALTH SOLUTIONS via NAVITUS HEALTH SOLUTIONS
2026 · third_quarter · 3T
Pharmacy Benefit Manger Reform, Patients Before Monopolies Act, Senior Access to Life Saving Drugs, IRA drug shortage, Drug Supply Chain reform
ERISA protection, Pharmacy Benefit Manager Reform, Patients Before Monopolies Act, Drug supply chain transparency reform.
Source: Senate LDA
Patients before Monopolies Act, drug supply chain reform.
Patients before Monopolies Act, Specialty pharmacy licensing and compensation, drug supply chain transparency reform.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Treasury, Dept of, White House Office
NAVITUS HEALTH SOLUTIONS via NAVITUS HEALTH SOLUTIONS
2026 · second_quarter · Q2
Patients before Monopolies Act, Specialty pharmacy licensing and compensation, drug supply chain transparency reform.
ERISA protection, Pharmacy Benefit Manager Reform, Patients Before Monopolies Act, Drug supply chain transparency reform.
Pharmacy Benefit Manger Reform, Patients Before Monopolies Act, Senior Access to Life Saving Drugs, IRA drug shortage, Drug Supply Chain reform
Patients before Monopolies Act, drug supply chain reform.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Treasury, Dept of, White House Office
NAVITUS HEALTH SOLUTIONS via NAVITUS HEALTH SOLUTIONS
2026 · first_quarter · Q1
ERISA protection, Pharmacy Benefit Manager Reform, Patients Before Monopolies Act
Patients before Monopolies Act, DOJ/FTC Investigation into PBMs
Pharmacy Benefit Manger Reform, Patients Before Monopolies Act, Senior Access to Life Saving Drugs, IRA drug shortage, Drug Supply Chain reform
Patients before Monopolies Act, Specialty pharmacy licensing and compensation
Filing targets: Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Treasury, Dept of, White House Office
NAVITUS HEALTH SOLUTIONS via NAVITUS HEALTH SOLUTIONS
2025 · fourth_quarter · Q4
Pharmacy Benefit Manger Reform, Patients Before Monopolies Act, Senior Access to Life Saving Drugs, IRA drug shortage
ERISA protection, Pharmacy Benefit Manager Reform, Patients Before Monopolies Act
Patients before Monopolies Act, Specialty pharmacy licensing and compensation
Patients before Monopolies Act, DOJ/FTC Investigation into PBMs
Filing targets: Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Treasury, Dept of, White House Office
NAVITUS HEALTH SOLUTIONS via NAVITUS HEALTH SOLUTIONS
2025 · third_quarter · Q3
Pharmacy Benefit Manger Reform, Patients Before Monopolies Act, Senior Access to Life Saving Drugs, IRA drug shortage
ERISA protection, Pharmacy Benefit Manager Reform, Patients Before Monopolies Act
Patients before Monopolies Act, Specialty pharmacy licensing and compensation
Patients before Monopolies Act, DOJ/FTC Investigation into PBMs
Filing targets: Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Treasury, Dept of
NAVITUS HEALTH SOLUTIONS via NAVITUS HEALTH SOLUTIONS
2025 · second_quarter · Q2
Pharmacy Benefit Manger Reform, Patients Before Monopolies Act, Senior Access to Life Saving Drugs
ERISA protection, Pharmacy Benefit Manager Reform, Patients Before Monopolies Act
Patients before Monopolies Act, Specialty pharmacy licensing and compensation
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Treasury, Dept of
NAVITUS HEALTH SOLUTIONS via NAVITUS HEALTH SOLUTIONS
2025 · first_quarter · 1A
Pharmacy Benefit Manger Reform, Patients Before Monopolies Act, Senior Access to Life Saving Drugs
ERISA protection, Pharmacy Benefit Manager Reform, Patients Before Monopolies Act
Patients before Monopolies Act, Specialty pharmacy licensing and compensation
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Treasury, Dept of
NAVITUS HEALTH SOLUTIONS via NAVITUS HEALTH SOLUTIONS
2025 · first_quarter · Q1
Pharmacy Benefit Manger Reform, Patients Before Monopolies Act, Senior Access to Life Saving Drugs
ERISA protection, Pharmacy Benefit Manager Reform, Patients Before Monopolies Act
Patients before Monopolies Act, Specialty pharmacy licensing and compensation
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Treasury, Dept of
NAVITUS HEALTH SOLUTIONS via NAVITUS HEALTH SOLUTIONS
2024 · fourth_quarter · Q4
Employee benefit plans and ERISA exemption and its impact to employers and plan sponsors/TPAs/PBMs
Speak about importance of competition, PBM transparency and rebates in relation to pharmacy coverage.
Pharmaceutical costs, pharmacy benefit manager transparency reform, specifically specialty pharmacy and generic drug options.
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Treasury, Dept of
NAVITUS HEALTH SOLUTIONS via NAVITUS HEALTH SOLUTIONS
2024 · third_quarter · Q3
Pharmaceutical costs, pharmacy benefit manager transparency reform, specifically specialty pharmacy and generic drug options.
Employee benefit plans and ERISA exemption and its impact to employers and plan sponsors/TPAs/PBMs
Speak about importance of competition, PBM transparency and rebates in relation to pharmacy coverage.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Treasury, Dept of
NAVITUS HEALTH SOLUTIONS via NAVITUS HEALTH SOLUTIONS
2024 · second_quarter · Q2
Employee benefit plans and ERISA exemption and its impact to employers and plan sponsors/TPAs/PBMs
Pharmaceutical costs, pharmacy benefit manager transparency reform, specifically specialty pharmacy and generic drug options.
Speak about importance of competition, PBM transparency and rebates in relation to pharmacy coverage.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Economic Council (NEC), SENATE, White House Office
NAVITUS HEALTH SOLUTIONS via NAVITUS HEALTH SOLUTIONS
2024 · first_quarter · Q1
Employee benefit plans and ERISA exemption and its impact to employers and plan sponsors/TPAs/PBMs
Pharmaceutical costs, pharmacy benefit manager transparency reform, specifically specialty pharmacy and generic drug options.
Speak about importance of competition, PBM transparency and rebates in relation to pharmacy coverage.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, White House Office
NAVITUS HEALTH SOLUTIONS via NAVITUS HEALTH SOLUTIONS
2023 · fourth_quarter · Q4
Speak about importance of competition, PBM transparency and rebates in relation to pharmacy coverage.
Pharmaceutical costs, pharmacy benefit manager transparency reform, specifically specialty pharmacy and generic drug options.
Employee benefit plans and ERISA exemption and its impact to employers and plan sponsors/TPAs/PBMs
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
NAVITUS HEALTH SOLUTIONS via NAVITUS HEALTH SOLUTIONS
2023 · third_quarter · Q3
Employee benefit plans and ERISA exemption and its impact to employers and plan sponsors/TPAs/PBMs
Speak about importance of competition, PBM transparency and rebates in relation to pharmacy coverage.
Pharmaceutical costs, pharmacy benefit manager transparency reform, specifically specialty pharmacy and generic drug options.
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
NAVITUS HEALTH SOLUTIONS via NAVITUS HEALTH SOLUTIONS
2023 · second_quarter · Q2
Employee benefit plans and ERISA exemption and its impact to employers and plan sponsors/TPAs/PBMs
Speak about importance of competition, PBM transparency and rebates in relation to pharmacy coverage.
Pharmaceutical costs, pharmacy benefit manager transparency reform, specifically specialty pharmacy and generic drug options.
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
NAVITUS HEALTH SOLUTIONS via NAVITUS HEALTH SOLUTIONS
2023 · first_quarter · 1A
Employee benefit plans and ERISA exemption and its impact to employers and plan sponsors/TPAs/PBMs
Speak about importance of competition, PBM transparency and rebates in relation to pharmacy coverage.
Pharmaceutical costs, specifically specialty pharmacy and generic drug options.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NAVITUS HEALTH SOLUTIONS via NAVITUS HEALTH SOLUTIONS
2023 · first_quarter · RR
PBM transparency, reporting and regulation of the industry.
PBM transparency, reporting and regulation of the industry.